Herts and Essex Fertility - IVF Spot Purchase NCL ICB

This procurement process involves a contract awarded for in vitro fertilisation services titled "Herts and Essex Fertility - IVF Spot Purchase NCL ICB" by NHS North Central London ICB. The contract has been awarded to the HERTS and ESSEX FERTILITY CENTRE LIMITED under the Provider Selection Regime (PSR) and follows a limited procurement method without prior publication of a call for competition. Located in London and classified under the health services industry, the procurement was initiated through the Health Care Services Regulations 2023 and does not fall under the Public Contracts Regulations 2015.

Notably, the service is a fertility treatment where patients have a choice of providers, confirming the status of a direct award. The contract was signed on 19 September 2025 and is currently active. This tender provides significant opportunities for businesses involved in healthcare services, specifically those offering in vitro fertilisation services.

The arrangement under the NHS framework opens avenues for small and medium-sized enterprises (SMEs) like the HERTS and ESSEX FERTILITY CENTRE LIMITED, which successfully secured the contract. Businesses with existing capabilities in delivering healthcare services and managing patient-provider choice scenarios can strategically leverage such contracts to expand their market presence and operational portfolio within the UK health sector.